Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.

Lythe V, Athauda D, Foley J, Mencacci NE, Jahanshahi M, Cipolotti L, Hyam J, Zrinzo L, Hariz M, Hardy J, Limousin P, Foltynie T.

J Parkinsons Dis · 2017-01-01

DOI: 10.3233/jpd-171172PMID: 28777757

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

[The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].

Senkevich KA, Miliukhina IV, Beletskaia MV, Gracheva EV, Kudrevatykh AV, Nikolaev MA, Emelyanov AK, Kopytova AE, Timofeeva AA, Yakimovskii AF, Pchelina SN.

Zh Nevrol Psikhiatr Im S S Korsakova · 2017-01-01

DOI: 10.17116/jnevro201711710181-86PMID: 29171494

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.

Jesús S, Huertas I, Bernal-Bernal I, Bonilla-Toribio M, Cáceres-Redondo MT, Vargas-González L, Gómez-Llamas M, Carrillo F, Calderón E, Carballo M, Gómez-Garre P, Mir P.

PLoS One · 2016-12-28

DOI: 10.1371/journal.pone.0167749PMID: 28030538

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Commentary: Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.

Fernandes HJ, Ryan BJ, Wade-Martins R.

Front Neurosci · 2016-12-23

DOI: 10.3389/fnins.2016.00578PMID: 28066164

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.

Thaler A, Gurevich T, Bar Shira A, Gana Weisz M, Ash E, Shiner T, Orr-Urtreger A, Giladi N, Mirelman A.

Parkinsonism Relat Disord · 2016-12-16

DOI: 10.1016/j.parkreldis.2016.12.014PMID: 28012950

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.

Pchelina S, Emelyanov A, Baydakova G, Andoskin P, Senkevich K, Nikolaev M, Miliukhina I, Yakimovskii A, Timofeeva A, Fedotova E, Abramycheva N, Usenko T, Kulabukhova D, Lavrinova A, Kopytova A, Garaeva L, Nuzhnyi E, Illarioshkin S, Zakharova E.

Neurosci Lett · 2016-10-22

DOI: 10.1016/j.neulet.2016.10.039PMID: 27780739

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.

Abreu GM, Valença DC, Campos M, da Silva CP, Pereira JS, Araujo Leite MA, Rosso AL, Nicaretta DH, Vasconcellos LF, da Silva DJ, Della Coletta MV, Dos Santos JM, Gonçalves AP, Santos-Rebouças CB, Pimentel MM.

Neurosci Lett · 2016-10-21

DOI: 10.1016/j.neulet.2016.10.040PMID: 27777137

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.

Cilia R, Tunesi S, Marotta G, Cereda E, Siri C, Tesei S, Zecchinelli AL, Canesi M, Mariani CB, Meucci N, Sacilotto G, Zini M, Barichella M, Magnani C, Duga S, Asselta R, Soldà G, Seresini A, Seia M, Pezzoli G, Goldwurm S.

Ann Neurol · 2016-10-03

DOI: 10.1002/ana.24777PMID: 27632223

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.

Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, Bernard B, Wszolek ZK, Ross OA, Dickson DW, Eidelberg D, Mattis PJ, Niethammer M, Yearout D, Hu SC, Cholerton BA, Smith M, Mata IF, Montine TJ, Edwards KL, Zabetian CP.

JAMA Neurol · 2016-10-01

DOI: 10.1001/jamaneurol.2016.2245PMID: 27571329

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

GBA p.T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis.

Mallett V, Ross JP, Alcalay RN, Ambalavanan A, Sidransky E, Dion PA, Rouleau GA, Gan-Or Z.

Neurol Genet · 2016-09-08

DOI: 10.1212/nxg.0000000000000104PMID: 27648471

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neuropsychiatric characteristics of GBA-associated Parkinson disease.

Swan M, Doan N, Ortega RA, Barrett M, Nichols W, Ozelius L, Soto-Valencia J, Boschung S, Deik A, Sarva H, Cabassa J, Johannes B, Raymond D, Marder K, Giladi N, Miravite J, Severt W, Sachdev R, Shanker V, Bressman S, Saunders-Pullman R.

J Neurol Sci · 2016-08-30

DOI: 10.1016/j.jns.2016.08.059PMID: 27772789

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.

Sanchez-Martinez A, Beavan M, Gegg ME, Chau KY, Whitworth AJ, Schapira AH.

Sci Rep · 2016-08-19

DOI: 10.1038/srep31380PMID: 27539639

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

404 makale bulundu

GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.

[The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].

GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.

Commentary: Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.

A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.

Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.

Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.

Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.

Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.

GBA p.T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis.

Neuropsychiatric characteristics of GBA-associated Parkinson disease.

Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.

Filtreler